Ferulic acid: A hope for Alzheimer’s disease therapy from plants

Nutrients

Volumn 7, Issue 7, 2015, Pages 5764-5782

  Sgarbossa, Antonella ^a   Giacomazza, Daniela ^b   Di Carlo, Marta ^b  

^a SCUOLA NORMALE SUPERIORE   (Italy)

^b CNR   (Italy)

Author keywords

Alzheimer s disease; Antioxidants; Apoptosis; Fibrillogenesis; Nanotechnology; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; FERULIC ACID; SCAVENGER; ANTIOXIDANT; COUMARIC ACID;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL SIGNALING ASSAY; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL FEATURE; DISEASE COURSE; HUMAN; INFLAMMATION; NANOTECHNOLOGY; OXIDATIVE STRESS; PROTEIN FUNCTION; REVIEW; CHEMISTRY; FERULA; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIOXIDANTS; COUMARIC ACIDS; FERULA; HUMANS;

EID: 84937422538     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7075246     Document Type: Review

References (99)

1. Sosulski, F.; Krygier, K.; Hogge, L. Free, esterified, and insoluble-bound phenolic acids. 3. Composition of phenolic acids in cereal and potato flours. J. Agric. Food Chem. 1982, 30, 337–340. [CrossRef]
2. Lempereur, I.; Rouau, X.; Abecassis, J. Genetic and agronomic variation in arabinoxylan and ferulic acid contents of durum wheat (Triticum durum L.) grain and its milling fractions. J. Cereal Sci. 1997, 25, 103–110. [CrossRef]
3. Kumar, N.; Pruthi, V. Potential applications of ferulic acid from natural sources. Biotechnol. Rep. 2014, 4, 86–93. [CrossRef]
4. Vanholme, R.; Demeds, B.; Morrel, K.; Ralph, J.; Boerjan, W. Lignin biosynthesis and structure. Plant Physiol. 2010, 153, 895–905. [CrossRef] [PubMed]
5. Strack, D. Metabolism of hydroxycinnamic acid conjugates. Bull. Liaison Groupe Polyphen. 1990, 15, 55–64.
6. Graf, E. Antioxidant potential of ferulic acid. Free Radic. Biol. Med. 1992, 3, 435–448. [CrossRef]
7. Rosazza, J.P.N.; Huang, Z.; Dostal, L.; Volm, T.; Rousseau, B. Review: Biocatalytic transformations of ferulic acid: An abundant aromatic natural product. J. Ind. Microbiol. 1995, 15, 457–471. [CrossRef] [PubMed]
8. Lyu, S.W.; Blum, U. Effects of ferulic acid, an allelopathic compound, on net P, K, and water uptake by cucumber seedlings in a split-root system. J. Chem. Ecol. 1990, 16, 2429–2439. [CrossRef] [PubMed]
9. Wojcicka, A. Cereal phenolic compounds as biopesticides of ceral aphids. Pol. J. Environ. Stud. 2010, 19, 1337–1343.
10. Suga, T.; Ohta, S.; Munesada, K.; Ide, N.; Kurokawa, M.; Shimizu, M.; Ohta, E. Endogenous pine wood nematicidal substances in pines, Pinus massoniana, P. strobus and P. palustris. Phytochemistry 1993, 33, 1395–1401. [CrossRef]
11. Putman, L.J.; Laks, P.E.; Pruner, M.S. Chemical constituents of black locust bark and their biocidal activity. Holzforschung 1989, 43, 219–224. [CrossRef]
12. Clifford, M.N. Chlorogenic acids and other cinnamates—Nature, occurrence and dietary burden. J. Sci. Food Agric. 1999, 79, 362–372. [CrossRef]
13. Konishi, Y.; Zhao, Z.; Shimizu, M. Phenolic acids are absorbed from rats stomach with different absorption rates. J. Agric. Food Chem. 2006, 54, 7539–7543. [CrossRef] [PubMed]
14. Yang, C.; Tian, Y.; Zhang, Z.J.; Xu, F.G.; Chen, Y. High-performance liquid chromatography-electrospray ionization mass spectrometry determination of sodium ferulate in human plasma. J. Pharm. Biomed. Anal. 2007, 43, 945–950. [CrossRef] [PubMed]
15. Szwajgier, D.; Jakubczyk, A. Biotransformation of ferulic acid by Lactobacillus acidophilus K1 and selected Bifidobacterium strains. Acta Sci. Pol. Technol. Aliment. 2010, 9, 45–59.
16. Rondini, L.; Peyrat-Maillard, M.N.; Marsset-Baglieri, A.; Fromentin, G.; Durand, P.; Tomè, D.; Prost, M.; Berset, C. Bound ferulic acid from bran is more bioavailable than the free compound in rat. J. Agric. Food Chem. 2004, 52, 4338–4343. [CrossRef] [PubMed]
17. Zhao, Z.; Egashira, Y.; Sanada, H. Ferulic acid sugar esters are recovered in rat plasma and urine mainly as the sulfoglucuronide of ferulic acid. J. Nutr. 2003, 133, 1355–1361. [PubMed]
18. Zhao, Z.; Egashira, Y.; Sanada, H. Digestion and absorption of ferulic acid sugar esters in rat gastrointestinal tract. J. Agric. Food Chem. 2003, 51, 5534–5539. [CrossRef] [PubMed]
19. Jacobson, E.A.; Newmark, H.; Baptista, J.; Bruce, W.R. A preliminary investigation of the metabolism of dietary phenolics in humans. Nutr. Rep. Int. 1983, 28, 1409–1417.
20. Bourne, L.; Paganga, G.; Baxter, D.; Hughes, P.; Rice-Evans, C. Absorption of ferulic acid from low-alcohol beer. Free Radic. Res. 2000, 32, 273–280. [CrossRef] [PubMed]
21. Virgili, F.; Pagana, G.; Bourne, L.; Rimbach, G.; Natella, F.; Rice-Evans, C. Ferulic acid excretion as a marker of consumption of a French maritime pine (Pinus maritima) bark extract. Free Radic. Biol. Med. 2000, 28, 1249–1256. [CrossRef]
22. Hermann, K. Occurrence and content of hydroxycinnamic and hydroxybenzoic acid compounds in foods. Crit. Rev. Food Sci. Nutr. 1989, 28, 315–347. [CrossRef] [PubMed]
23. Zhao, Z.; Egashira, Y.; Sanada, H. Ferulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liver. J. Nutr. 2004, 134, 3083–3088. [PubMed]
24. Kern, S.M.; Bennett, R.N.; Needs, P.W.; Mellon, F.A.; Kroon, P.A.; Garcia-Conesa, M.T. Characterization of metabolites of hydroxycinnamates in the in vitro model of human small intestinal epithelium Caco-2 cells. J. Agric. Food Chem. 2003, 51, 7884–7891. [CrossRef] [PubMed]
25. Uraji, M.; Kimura, M.; Inoue, Y.; Kawakami, K.; Kumagay, Y.; Harazono, K.; Hatanaka, T. Enzymatic production of ferulic acid from defatted rice bran by using a combination of bacterial enzymes. Appl. Biochem. Biotechnol. 2013, 171, 1085–1093. [CrossRef] [PubMed]
26. Dutt, S. General synthesis of α-unsaturated acids from malonic acid. Q. J. Chem. Soc. 1925, 1, 297–301.
27. Srinivasan, M.; Sudheer, A.R.; Menon, V.P. Ferulic acid: Therapeutic potential through its antioxidant property. J. Clin. Biochem. Nutr. 2007, 40, 92–100. [CrossRef] [PubMed]
28. Kanski, J.; Aksenova, M.; Stoyanova, A.; Butterfield, D.A. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: Structure-activity studies. J. Nutr. Biochem. 2002, 13, 273–281. [CrossRef]
29. Itagaki, S.; Kurokawa, T.; Nakata, C.; Saito, Y.; Oikawa, S.; Kobayashi, M.; Hirano, T.; Iseki, K. In vitro and in vivo antioxidant properties of ferulic acid: A comparative study with other natural oxidation inhibitors. Food Chem. 2009, 114, 466–471. [CrossRef]
30. Rocha, L.D.; Monteiro, M.C.; Teodoro, A.J. Anticancer properties of hydroxicinnamic acids—A review. Cancer Clinical Oncol. 2012, 1, 109–121.
31. Serafim, T.L.; Carvalho, F.S.; Marques, M.P.; Calheiros, R.; Silva, T. Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells. Chem. Res. Toxicol. 2011, 16, 763–774. [CrossRef] [PubMed]
32. Ohsaki, A.Y.; Shirakawa, H.; Koseki, T.; Komai, M. Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats. J. Agric. Food Chem. 2008, 56, 2825–2830.
33. Lin, F.H.; Lin, J.Y.; Gupta, R.D.; Tournas, J.A.; Burch, J.A.; Selim, M.A.; Monteiro-Riviere, N.A.; Grichnick, J.M.; Zielinski, J.; Pinnell, S.R. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J. Investig. Dermatol. 2005, 125, 826–832. [CrossRef] [PubMed]
34. Jung, E.H.; Kim, S.R.; Hwang, I.K.; Ha, T.Y. Hypoglycemic effects of a phenolic acid fraction of rice bran and ferulic acid in C57BL/KsJ-db/db mice. J. Agric. Food Chem. 2007, 55, 9800–9804. [CrossRef] [PubMed]
35. Fetoni, A.R.; de Bartolo, P.; Eramo, S.L.M.; Rolesi, R.; Paciella, F.; Bergamini, C.; Fato, R.; Paludetti, G.; Petrosini, L.; Troiani, L. Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: Cochlear and cortical responses after an increase in antioxidant defense. J. Neurosci. 2013, 33, 4011–4023. [CrossRef] [PubMed]
36. Calabrese, V.; Calafato, S.; Puleo, E.; Cornelius, C.; Sapienza, M.; Morganti, P.; Mancuso, C. Redox regulation of cellular stress response by ferulic acid ethyl ester in human dermal fibroblasts: Role of vitagenes. Clin. Dermatol. 2008, 26, 358–363. [CrossRef] [PubMed]
37. Ferri, C.P.; Prince, M.; Brayne, C.; Brodaty, H.; Fratiglioni, L.; Ganguli, M.; Hall, K.; Hasegawa, K.; Hendrie, H.; Huang, Y.; et al. Global prevalence of dementia: A Delphi consensus study. Lancet 2005, 366, 2112–2117. [CrossRef]
38. Mancuso, C.; Siciliano, R.; Barone, E.; Butterfield, D.A.; Preziosi, P. Pharmacologists and Alzheimer disease therapy: To boldly go where no scientist has gone before. Expert. Opin. Investig. Drugs 2011, 20, 1243–1261. [CrossRef] [PubMed]
39. Mannini, B.; Mulvihill, E.; Sgromo, C.; Cascella, R.; Khodarahmi, R.; Ramazzotti, M.; Dobson, C.M.; Cecchi, C.; Chiti, F. Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity. ACS Chem. Biol. 2014, 9, 2309–2317. [CrossRef] [PubMed]
40. Picone, P.; Carrotta, R.; Montana, G.; Nobile, M.R.; San Biagio, P.L.; di Carlo, M. Aβ-oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures. Biophys. J. 2009, 96, 4200–4211. [CrossRef] [PubMed]
41. Novitskaya, V.; Bocharova, O.V.; Bronstein, I.; Baskakov, I.V. Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J. Biol. Chem. 2006, 281, 13828–13836. [CrossRef] [PubMed]
42. Bucciantini, M.; Nosi, D.; Forzan, M.; Russo, E.; Calamai, M.; Pieri, L.; Formigli, L.; Quercioli, F.; Soria, S.; Pavone, F.; et al. Toxic effects of amyloid fibrils on cell membranes: The importance of ganglioside GM 1. FASEB J. 2012, 26, 818–831. [CrossRef] [PubMed]
43. Bucciantini, M.; Rigacci, S.; Stefani, M. Amyloid aggregation: Role of biological membranes and the aggregate–membrane system. J. Phys. Chem. Lett. 2014, 5, 517–527. [CrossRef]
44. Gharibyan, A.L.; Zamotin, V.; Yanamandra, K.; Moskaleva, O.S.; Margulis, B.A.; Kostanyan, I.A.; Morozova-Roche, L.A. Lysozyme amyloid oligomers and fibrils induce cellulardeath via different apoptotic/necrotic pathways. J. Mol. Biol. 2007, 365, 1337–1349. [CrossRef] [PubMed]
45. Lee, C.C.; Nayak, A.; Sethuraman, A.; Belfort, G.; McRae, G.J. A three-stage kinetic model of amyloid fibrillation. Biophys. J. 2007, 92, 3448–3458. [CrossRef] [PubMed]
46. Morris, A.M.; Watzky, M.A.; Agar, J.N.; Finke, R.G. Fitting Neurological Protein Aggregation Kinetic Data via a 2-Step, Minimal/“Ockham’s Razor” Model: The Finke-Watzky Mechanism of Nucleation Followed by Autocatalytic Surface Growth. Biochemistry 2008, 47, 2413–2427. [CrossRef] [PubMed]
47. Gazit, E. A possible role for π-stacking in self-assembly of amyloid fibrils. FASEB J. 2002, 16, 77–83. [CrossRef] [PubMed]
48. Hunter, C.A.; Lawson, K.R.; Perkins, J.; Urch, C.J. Aromatic interactions. J. Chem. Soc. 1999, 2, 651–669. [CrossRef]
49. Lorenzo, A.; Yankner, B.A. β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 1994, 91, 12243–12247. [CrossRef] [PubMed]
50. Lee, V.M. Amyloid binding ligands as Alzheimer’s disease therapies. Neurobiol. Aging 2002, 23, 1039–1042. [CrossRef]
51. Bemporad, F.; Taddei, N.; Stefani, M.; Chiti, F. Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase. Protein Sci. 2006, 15, 862–870. [CrossRef] [PubMed]
52. Porat, Y.; Abramowitz, A.; Gazit, E. Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chem. Biol. Drug Des. 2006, 67, 27–37. [CrossRef] [PubMed]
53. Sgarbossa, A. Natural biomolecules and protein aggregation: Emerging strategies against amyloidogenesis. Int. J. Mol. Sci. 2012, 13, 17121–17137. [CrossRef] [PubMed]
54. Yang, F.; Lim, G.P.; Begum, A.N.; Ubeda, O.J.; Simmons, M.R.; Ambegaokar, S.S.; Chen, P.P.; Kayed, R.; Glabe, C.G.; Frautschy, S.A.; et al. Curcumin inhibits formation of amyloid-beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 2005, 280, 5892–5901. [CrossRef] [PubMed]
55. Howlett, D.R.; George, A.R.; Owen, D.E.; Ward, R.V.; Markwell, R.E. Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer β-amyloid fibril formation. Biochem. J. 1999, 343, 419–423. [CrossRef]
56. Sgarbossa, A.; Buselli, D.; Lenci, F. In vitro perturbation of aggregation processes in β-amyloid peptides: A spectroscops study. FEBS Lett. 2008, 582, 3288–3292. [CrossRef] [PubMed]
57. Bramanti, E.; Lenci, F.; Sgarbossa, A. Effects of Hypericin on the Structure and Aggregation Properties of β-Amyloid Peptides. Eur. Biophys. J. 2010, 39, 1493–1501. [CrossRef] [PubMed]
58. Picone, P.; Bondi, M.L.; Montana, G.; Bruno, A.; Pitarresi, G.; Giammona, G.; di Carlo, M. Ferulic acid inhibits oxidative stress and cell death induced by Aβ oligomers: Improved delivery by solid lipid nanoparticles. Free Radical Res. 2009, 43, 1133–1145. [CrossRef] [PubMed]
59. Bondì, M.L.; Montana, G.; Craparo, E.F.; Picone, P.; Capuano, G.; di Carlo, M.; Giammona, G. Ferulic acid loaded lipid nanostructures as drug delivery systems for Alzheimer’s disease: preparation, characterization and cytotoxicity studies. Curr. Nanosci. 2009, 5, 26–32. [CrossRef]
60. Hamaguchi, T.; Ono, K.; Yamad, M. Curcumin and Alzheimer’s disease. CNS Neurosci. Ther. 2010, 16, 285–297. [CrossRef] [PubMed]
61. Ono, K.; Hirohata, M.; Yamada, M. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro. Biochem. Biophys. Res. Commun. 2005, 336, 444–449. [CrossRef] [PubMed]
62. Hamaguchi, T.; Ono, K.; Murase, A.; Yamada, M. Phenolic compounds prevent Alzheimer pathology through different effects on the amyloid-beta aggregation pathway. Am. J. Pathol. 2009, 175, 2557–2565. [CrossRef]
63. Kim, H.S.; Cho, J.Y.; Kim, D.H.; Yan, J.J.; Lee, H.K.; Suh, H.W.; Song, D.K. Inhibitory effects of long term administration of ferulic acid on microglial activation induced by intercerebroventricular injection of beta amyloid peptide (1–42) in mice. Biol. Pharm. Bull. 2004, 27, 120–121. [CrossRef] [PubMed]
64. Yan, J.J.; Cho, J.Y.; Kim, H.S.; Kim, K.L.; Jung, J.S.; Huh, S.O.; Suh, H.W.; Kim, Y.H.; Song, D.K. Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 2001, 133, 89–96. [CrossRef] [PubMed]
65. Sultana, R.; Ravagna, A.; Mohmmad-Abdul, H.; Calabrese, V.; Butterfield, D.A. Ferulic acid ethyl ester protects neurons against amyloid β-peptide(1–42)-induced oxidative stress and neurotoxicity: Relationship to antioxidant activity. J. Neurochem. 2005, 92, 749–758. [CrossRef] [PubMed]
66. Ono, K.; Li, L.; Takamura, Y.; Yoshiike, Y.; Zhu, L. Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding. J. Biol. Chem. 2012, 287, 14631–14643. [CrossRef] [PubMed]
67. Jagota, S.; Rajadas, J. Effect of phenolic compounds against A_ aggregation and A_-induced toxicity in transgenic C. elegans. Neurochem. Res. 2012, 37, 40–48. [CrossRef] [PubMed]
68. Sgarbossa, A.; Monti, S.; Lenci, F.; Bramanti, E.; Bizzarri, R.; Barone, V. The effects of ferulic acid on β-amyloid fibrillar structures investigated through experimental and computational techniques. Biochim. Biophys. Acta 2013, 1830, 2924–2937. [CrossRef] [PubMed]
69. Cui, L.; Zhang, Y.; Cao, H.; Wang, Y.; Teng, T.; Ma, G.; Li, Y.; Zhang, Y. Ferulic acid inhibits the transition of amyloid-β42 monomers to oligomers but accelerates the transition from oligomers to fibrils. J. Alzheimer’s Dis. 2013, 37, 19–28.
70. Bramanti, E.; Fulgentini, L.; Bizzarri, R.; Lenci, F.; Sgarbossa, A. β-Amyloid amorphous aggregates induced by the small natural molecule, ferulic acid. J. Phys. Chem. B. 2013, 117, 13816–13821. [CrossRef] [PubMed]
71. Chauhan, V.; Chauhan, A. Oxidative stress in Alzheimer’s Disease. Pathophysiology 2006, 13, 195–208. [CrossRef] [PubMed]
72. Di Carlo, M.; Giacomazza, D.; Picone, P.; Nuzzo, D.; San Biagio, P.L. Are oxidative stress and mitochondrial dysfunction the key players in the neurodegerative diseases? Free Radic. Res. 2012, 46, 1327–1338. [CrossRef] [PubMed]
73. Gupta, V.K.; Sharma, S.K. Plants as natural antioxidants. Nat. Prod. Radiance 2005, 5, 326–334.
74. Rathore, G.S.; Suthar, M.; Pareek, A.; Gupta, R.N. Nutritional antioxidants: A battle for better health. J. Nat. Pharm. 2011, 2, 2–14. [CrossRef]
75. Vasto, S.; Barera, A.; Rizzo, C.; di Carlo, M.; Caruso, C.; Panotopoulous, G. Mediterranean diet and longevity: An example of nutraceuticals? Curr. Vasc. Pharm. 2014, 12, 735–738. [CrossRef]
76. Vasto, S.; Buscemi, S.; Barera, A.; di Carlo, M.; Accardi, G.; Caruso, C. Mediterranean diet and healthy ageing: A Sicilian perspective. Gerontology 2014, 60, 508–518. [CrossRef] [PubMed]
77. Barone, E.; Calabrese, V.; Mancuso, C. Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontology 2009, 10, 97–108. [CrossRef] [PubMed]
78. Markesbery, W.R. Oxidative stress hypothesis in Alzheimer’s disease. Free Radic. Biol. Med. 1997, 23, 134–147. [CrossRef]
79. Pappolla, M.A.; Chyan, Y.J.; Omar, R.A.; Hsiao, K.; Perry, G.; Smith, M.A.; Bozner, P. Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer’s disease. A chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 1998, 152, 871–877. [PubMed]
80. Goldsbury, C.; Whiteman, I.T.; Jeong, E.V.; Lim, Y.A. Oxidative stress increases levels of endogenous amyloid-β peptides secreted from primary chick brain neurons. Aging Cell 2008, 7, 771–775. [CrossRef] [PubMed]
81. Mancuso, C.; Scapagnini, G.; Curro, D.; Giuffrida Stella, A.M.; de Marco, C.; Butterfield, D.A.; Calabrese, V. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci. 2007, 12, 1107–1123. [CrossRef] [PubMed]
82. Cho, J.Y.; Kim, H.S.; Kim, D.H.; Yan, J.J.; Suh, H.W.; Song, D.K. Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of β-amyloid peptide (1–42) in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29, 901–907. [CrossRef] [PubMed]
83. Yan, J.J.; Jung, J.S.; Kim, T.K.; Hasan, A.; Hong, C.W.; Nam, J.S.; Song, D.K. Protective effects of ferulic acid in amyloid precursor protein plus presenilin-1 transgenic mouse model of Alzheimer disease. Biol. Pharm. Bull. 2013, 36, 140–143. [CrossRef] [PubMed]
84. Cheng, C.Y.; Su, S.Y.; Tang, N.Y.; Ho, T.Y.; Chiang, S.Y.; Hsieh, C.L. Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats. Brain Res. 2008, 1209, 136–150. [CrossRef] [PubMed]
85. Cheng, C.Y.; Su, S.Y.; Tang, N.Y.; Ho, T.Y.; Lo, W.Y.; Hsieh, C.L. Ferulic acid inhibits nitric oxide-induced apoptosis by enhancing GABAB1 receptor expression in transient focal cerebral ischemia in rats. Acta Pharmacol. Sin. 2010, 31, 889–899. [CrossRef] [PubMed]
86. Koh, P.O. Ferulic acid prevents the cerebral ischemic injury-induced decrease of Akt and Bad phosphorylation. Neurosci. Lett. 2012, 507, 156–160. [CrossRef] [PubMed]
87. Yabe, T.; Hirahara, H.; Harada, N.; Ito, N.; Nagai, T.; Sanagi, T.; Yamada, H. Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience. 2010, 165, 515–524. [CrossRef] [PubMed]
88. Mori, T.; Koyama, N.; Guillot-Sestier, M.V.; Tan, J.; Town, T. Ferulic acid is a nutraceutical β-secretase modulator that improves behavioral impairment and Alzheimer-like pathology in transgenic mice. PLoS ONE 2013, 8, e55774. [CrossRef] [PubMed]
89. Wada, T.; Penninge, J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004, 23, 2838–2849. [CrossRef] [PubMed]
90. Robinson, M.J.; Cobb, M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 1997, 9, 180–186. [CrossRef]
91. Wang, J.; Valmikinathan, C.M.; Yu, X. Nanostructures for bypassing blood brain barrier. Curr. Bioact. Compd. 2009, 5, 195–205. [CrossRef]
92. Zhou, H.; Li, X.M.; Meinkoth, J.; Pittman, R.N. Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell Biol. 2000, 151, 483–494. [CrossRef] [PubMed]
93. Jin, Y.; Yan, E.Z.; Fan, Y.; Zong, Z.H.; Qi, Z.M.; Li, Z. Sodium ferulate prevent amyloid-beta-induced neurotoxicity through suppression of p38 MAPK and upregulation of ERK-1/2 and Akt/ protein kinase B in rat hippocampus. Acta Pharmacol. Sin. 2005, 26, 943–951. [CrossRef] [PubMed]
94. Jin, Y.; Fan, Y.; Yan, E.Z.; Liu, Z.; Zong, Z.H.; Qi, Z.M. Effects of sodium ferulate on amyloid-β-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus. Acta Pharmacol. Sin. 2006, 27, 1309–1316. [CrossRef] [PubMed]
95. Mancuso, C.; Santangelo, R. Ferulic acid: Pharmacological and toxicological aspects. Food Chem. Toxicol. 2014, 65, 185–195. [CrossRef] [PubMed]
96. Reddy, A.P.; Parthiban, S.; Vikneswari, A.; Senthilkumar, G.P. A modern review on solid lipid nanoparticles as novel controlled drug delivery system. Int. J. Res. Pharm. Nano Sci. 2014, 3, 313–325.
97. Wu, W.; Lee, S.Y.; Wu, X.; Tyler, J.Y.; Wang, H.; Ouyang, Z.; Park, K.; Xu, X.M.; Cheng, J.X. Neuroprotective ferulic acid (FA)-glycol chitosan (GC) nanoparticles for functional restoration of traumatically injured spinal cord. Biomaterials 2014, 35, 2355–2364. [CrossRef] [PubMed]
98. Trombino, S.; Cassano, R.; Ferrarelli, T.; Barone, E.; Picci, N.; Mancuso, C. Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf. B Biointerfaces 2013, 109, 273–279. [CrossRef] [PubMed]
99. Mancuso, C. Key factors which concur to the correct therapeutic evaluation of herbal products in free radical-induced diseases. Front. Pharm. 2015, 6, 86. [CrossRef] [PubMed]